Suspected cancer: recognition and referral (NG12)Product type:GuidanceProgramme:NICE guidelineLast updated: 2 October 2023Published: 23 June 2015
Olaparib for maintenance treatment of BRCA mutation-positive metastatic pancreatic cancer after platinum-based chemotherapy (terminated appraisal) (TA750)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 8 December 2021
Endoscopic bipolar radiofrequency ablation for treating biliary obstruction caused by cancer (IPG614)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 23 May 2018
Pancreatic cancer in adults: diagnosis and management (NG85)Product type:GuidanceProgramme:NICE guidelinePublished: 7 February 2018
Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancer (TA476)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 6 September 2017
Irreversible electroporation for treating pancreatic cancer (IPG579)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 3 May 2017
Pegylated liposomal irinotecan for treating pancreatic cancer after gemcitabine (TA440)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 26 April 2017
Autologous pancreatic islet cell transplantation for improved glycaemic control after pancreatectomy (IPG274)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 24 September 2008
Laparoscopic distal pancreatectomy (IPG204)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 24 January 2007
Endoscopic bipolar radiofrequency ablation for malignant biliary obstructionStatus:Awaiting developmentProgramme:Interventional procedures guidanceExpected publication date: 13 November 2024
Endoscopic bipolar radiofrequency ablation for treating biliary obstruction caused by cholangiocarcinoma or pancreatic adenocarcinomaStatus:In developmentProgramme:Interventional procedures guidanceExpected publication date: TBC
Pancreas SABRStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC
Lutetium oxodotreotide with octreotide for newly diagnosed unresectable or metastatic gastroenteropancreatic neuroendocrine tumours [ID6315]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Percutaneous intraductal radiofrequency ablation for malignant biliary obstructionStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC